American Cannabis Company, Inc.
AMMJ
$0.0127
$0.00010.79%
| Weiss Ratings | AMMJ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D- | |||
| Reward Grade | E | |||
| Rating Factors | AMMJ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Fair | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | AMMJ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -0.07 | |||
| Price History | AMMJ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -6.25% | |||
| 30-Day Total Return | -18.92% | |||
| 60-Day Total Return | -27.42% | |||
| 90-Day Total Return | -37.93% | |||
| Year to Date Total Return | -18.92% | |||
| 1-Year Total Return | -66.54% | |||
| 2-Year Total Return | -82.00% | |||
| 3-Year Total Return | -95.87% | |||
| 5-Year Total Return | -97.69% | |||
| 52-Week High % Change | -88.97% | |||
| 52-Week Low % Change | 92.00% | |||
| Price | AMMJ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.09 | |||
| 52-Week Low Price | $0.01 | |||
| 52-Week Low Price (Date) | Jan 12, 2024 | |||
| 52-Week High Price (Date) | Sep 06, 2023 | |||
| Valuation | AMMJ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 1.67M | |||
| Enterprise Value | 2.89M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | 0.00 | |||
| Earnings Per Share Growth | -91.63% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.06 | |||
| Price/Book (Q) | 1.13 | |||
| Enterprise Value/Revenue (TTM) | 0.22 | |||
| Price | $0.01 | |||
| Enterprise Value/EBITDA (TTM) | 18.97 | |||
| Enterprise Value/EBIT | -21.85 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | AMMJ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 85.73M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | AMMJ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 303 974 4770 | |||
| Address | 200 Union Street Lakewood, CO 80228 | |||
| Website | www.americancannabisconsulting.com | |||
| Country | United States | |||
| Year Founded | 2001 | |||
| Profitability | AMMJ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -1.01% | |||
| Profit Margin | -1.11% | |||
| Management Effectiveness | AMMJ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -2.04% | |||
| Return on Equity | -- | |||
| Income Statement | AMMJ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 13.49M | |||
| Total Revenue (TTM) | 13.49M | |||
| Revenue Per Share | $0.16 | |||
| Gross Profit (TTM) | 2.36M | |||
| EBITDA (TTM) | 158.40K | |||
| EBIT (TTM) | -137.50K | |||
| Net Income (TTM) | -151.00K | |||
| Net Income Avl. to Common (TTM) | -151.00K | |||
| Total Revenue Growth (Q YOY) | -71.75% | |||
| Earnings Growth (Q YOY) | 60.47% | |||
| EPS Diluted (TTM) | 0.00 | |||
| EPS Diluted Growth (Q YOY) | 60.87% | |||
| Balance Sheet | AMMJ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 8.90K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 803.30K | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 1.37M | |||
| Current Ratio (Q) | 0.389 | |||
| Book Value Per Share (Q) | $0.01 | |||
| Total Assets (Q) | 4.17M | |||
| Total Current Liabilities (Q) | 2.07M | |||
| Total Debt (Q) | 1.23M | |||
| Total Liabilities (Q) | 2.80M | |||
| Total Common Equity (Q) | 1.37M | |||
| Cash Flow | AMMJ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -27.50K | |||
| Cash from Financing (TTM) | 443.00K | |||
| Net Change in Cash (TTM) | -182.80K | |||
| Levered Free Cash Flow (TTM) | -382.00K | |||
| Cash from Operations (TTM) | -598.30K | |||
